M A Rookus1, F E van Leeuwen. 1. Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Abstract
BACKGROUND: In general, no association has been found between spontaneous abortion (naturally occurring termination of a pregnancy) and the risk for breast cancer. With respect to induced abortion (termination of a pregnancy by artificial means), the results have been more inconclusive. A positive association was found in five studies, no association was found in six studies, and a negative association was found in the only cohort study. It is thought that part of the inconsistency of the reported results may be attributable to reporting (recall) bias, since all but two studies on induced abortion used the case-control design and were based only on information obtained from study subjects. In comparison with breast cancer case patients, healthy control subjects may be more reluctant to report on a controversial, emotionally charged subject such as induced abortion. Thus, differential underreporting may be a cause of spurious associations in case-control studies. PURPOSE: Our goal was threefold: 1) to evaluate the relationship between a history of induced or spontaneous abortion and the risk for breast cancer in a Dutch population-based, case-control study; 2) to examine reporting bias by comparing risks between two geographic areas (i.e., western regions and southeastern regions in The Netherlands that differ in prevalence of and attitudes toward induced abortion); and 3) to compare reporting bias in data on induced abortion with reporting bias in data on oral contraceptive use. METHODS: Data analyzed in this study were obtained from 918 women (20-54 years of age at diagnosis) who were diagnosed with invasive breast cancer during the period from 1986 through 1989 and had been initially enrolled in a population-based, case-control study investigating oral contraceptive use and breast cancer risk. The women resided in one of four geographic areas that were covered by Regional Cancer Registries: two western regions (Amsterdam and West) and two southeastern regions (East and Eindhoven). Each case patient was pair-matched, on the basis of age (within 1 year) and region, with a control subject who was randomly selected from municipal registries that fully covered the Dutch population. Both the case patients and the control subjects were interviewed at home by the same trained interviewer, who used a structured questionnaire. Reporting bias was examined indirectly by comparing risks between the western and the southeastern regions of the country, which differ in the prevalence of and attitude toward induced abortion. Multivariate conditional logistic regression methods for individually matched case-control studies were used to estimate relative risks (RRs). Reported P values are two-sided. RESULTS AND CONCLUSION: Among parous women, a history of induced abortion was associated with a 90% increased risk for breast cancer (adjusted RR = 1.9; 95% confidence interval [CI] = 1.1-3.2). Among nulliparous women, no association between induced abortion and breast cancer was found. Neither among parous women nor among nulliparous women was a history of spontaneous abortion related to the risk for breast cancer. The association between induced abortion and breast cancer was stronger in the southeastern regions of the country, which have a predominantly Roman Catholic population, than in the western regions (adjusted RR = 14.6 [95% CI = 1.8-120.0] versus adjusted RR = 1.3 [95% CI = 0.7-2.6], respectively; test of difference between regions, P = .017), suggesting reporting bias. Support for reporting bias as an explanation for the regional differences was also found in data supplied by both study subjects and their physicians on the use of oral contraceptives. In comparison with physicians, control subjects in the southeastern regions underreported the duration of their oral contraceptive use by 6.3 months more than control subjects in the western regions (P = .007)...
BACKGROUND: In general, no association has been found between spontaneous abortion (naturally occurring termination of a pregnancy) and the risk for breast cancer. With respect to induced abortion (termination of a pregnancy by artificial means), the results have been more inconclusive. A positive association was found in five studies, no association was found in six studies, and a negative association was found in the only cohort study. It is thought that part of the inconsistency of the reported results may be attributable to reporting (recall) bias, since all but two studies on induced abortion used the case-control design and were based only on information obtained from study subjects. In comparison with breast cancer case patients, healthy control subjects may be more reluctant to report on a controversial, emotionally charged subject such as induced abortion. Thus, differential underreporting may be a cause of spurious associations in case-control studies. PURPOSE: Our goal was threefold: 1) to evaluate the relationship between a history of induced or spontaneous abortion and the risk for breast cancer in a Dutch population-based, case-control study; 2) to examine reporting bias by comparing risks between two geographic areas (i.e., western regions and southeastern regions in The Netherlands that differ in prevalence of and attitudes toward induced abortion); and 3) to compare reporting bias in data on induced abortion with reporting bias in data on oral contraceptive use. METHODS: Data analyzed in this study were obtained from 918 women (20-54 years of age at diagnosis) who were diagnosed with invasive breast cancer during the period from 1986 through 1989 and had been initially enrolled in a population-based, case-control study investigating oral contraceptive use and breast cancer risk. The women resided in one of four geographic areas that were covered by Regional Cancer Registries: two western regions (Amsterdam and West) and two southeastern regions (East and Eindhoven). Each case patient was pair-matched, on the basis of age (within 1 year) and region, with a control subject who was randomly selected from municipal registries that fully covered the Dutch population. Both the case patients and the control subjects were interviewed at home by the same trained interviewer, who used a structured questionnaire. Reporting bias was examined indirectly by comparing risks between the western and the southeastern regions of the country, which differ in the prevalence of and attitude toward induced abortion. Multivariate conditional logistic regression methods for individually matched case-control studies were used to estimate relative risks (RRs). Reported P values are two-sided. RESULTS AND CONCLUSION: Among parous women, a history of induced abortion was associated with a 90% increased risk for breast cancer (adjusted RR = 1.9; 95% confidence interval [CI] = 1.1-3.2). Among nulliparous women, no association between induced abortion and breast cancer was found. Neither among parous women nor among nulliparous women was a history of spontaneous abortion related to the risk for breast cancer. The association between induced abortion and breast cancer was stronger in the southeastern regions of the country, which have a predominantly Roman Catholic population, than in the western regions (adjusted RR = 14.6 [95% CI = 1.8-120.0] versus adjusted RR = 1.3 [95% CI = 0.7-2.6], respectively; test of difference between regions, P = .017), suggesting reporting bias. Support for reporting bias as an explanation for the regional differences was also found in data supplied by both study subjects and their physicians on the use of oral contraceptives. In comparison with physicians, control subjects in the southeastern regions underreported the duration of their oral contraceptive use by 6.3 months more than control subjects in the western regions (P = .007)...
Entities:
Keywords:
Abortion, Induced; Abortion, Spontaneous; Bias; Biology; Breast Cancer; Cancer; Data Collection; Data Reporting; Developed Countries; Diseases; Error Sources; Europe; Family Planning; Fertility Control, Postconception; Measurement; Neoplasms; Netherlands; Pregnancy Complications; Research Methodology; Research Report; Risk Factors; Western Europe
Authors: David H Brewster; Diane L Stockton; Richard Dobbie; Diana Bull; Valerie Beral Journal: J Epidemiol Community Health Date: 2005-04 Impact factor: 3.710
Authors: Jennifer Gaudie; Francis Mitrou; David Lawrence; Fiona J Stanley; Sven R Silburn; Stephen R Zubrick Journal: BMC Public Health Date: 2010-02-11 Impact factor: 3.295
Authors: Oluwadamilola M Fayanju; Donna B Jeffe; Leisha Elmore; Deborah N Ksiazek; Julie A Margenthaler Journal: Ann Surg Oncol Date: 2012-10-16 Impact factor: 5.344
Authors: Sonia S Maruti; Walter C Willett; Diane Feskanich; Beverly Levine; Bernard Rosner; Graham A Colditz Journal: Cancer Causes Control Date: 2008-11-15 Impact factor: 2.506
Authors: Marieke G M Braem; N Charlotte Onland-Moret; Leo J Schouten; Roy F P M Kruitwagen; Annekatrin Lukanova; Naomi E Allen; Petra A Wark; Anne Tjønneland; Louise Hansen; Christina Marie Braüner; Kim Overvad; Françoise Clavel-Chapelon; Nathalie Chabbert-Buffet; Birgit Teucher; Anna Floegel; Heiner Boeing; Antonia Trichopoulou; George Adarakis; Maria Plada; Sabina Rinaldi; Veronika Fedirko; Isabelle Romieu; Valeria Pala; Rocco Galasso; Carlotta Sacerdote; Domenico Palli; Rosario Tumino; H Bas Bueno-de-Mesquita; Inger Torhild Gram; Oxana Gavrilyuk; Eiliv Lund; Maria-José Sánchez; Catalina Bonet; Maria-Dolores Chirlaque; Nerea Larrañaga; Aurelio Barricarte Gurrea; Jose R Quirós; Annika Idahl; Nina Ohlson; Eva Lundin; Karin Jirström; Salma Butt; Konstantinos K Tsilidis; Kay-Tee Khaw; Nick Wareham; Elio Riboli; Rudolf Kaaks; Petra H M Peeters Journal: PLoS One Date: 2012-05-18 Impact factor: 3.240
Authors: Alice W Lee; Stacey Rosenzweig; Ashley Wiensch; Susan J Ramus; Usha Menon; Aleksandra Gentry-Maharaj; Argyrios Ziogas; Hoda Anton-Culver; Alice S Whittemore; Weiva Sieh; Joseph H Rothstein; Valerie McGuire; Nicolas Wentzensen; Elisa V Bandera; Bo Qin; Kathryn L Terry; Daniel W Cramer; Linda Titus; Joellen M Schildkraut; Andrew Berchuck; Ellen L Goode; Susanne K Kjaer; Allan Jensen; Susan J Jordan; Roberta B Ness; Francesmary Modugno; Kirsten Moysich; Pamela J Thompson; Marc T Goodman; Michael E Carney; Jenny Chang-Claude; Mary Anne Rossing; Holly R Harris; Jennifer Anne Doherty; Harvey A Risch; Lilah Khoja; Aliya Alimujiang; Minh Tung Phung; Katharine Brieger; Bhramar Mukherjee; Paul D P Pharoah; Anna H Wu; Malcolm C Pike; Penelope M Webb; Celeste Leigh Pearce Journal: J Natl Cancer Inst Date: 2021-03-01 Impact factor: 13.506